Cano Health, Inc.
CANO · NYSE
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $134,074 | $733,711 | $458,130 | $669,944 |
| - Cash | $41,331 | $27,721 | $44,888 | $27,329 |
| + Debt | $1,241,396 | $1,231,571 | $1,217,608 | $1,199,715 |
| Enterprise Value | $1,334,139 | $1,937,561 | $1,630,850 | $1,842,330 |
| Revenue | $788,073 | $766,746 | $866,909 | $680,373 |
| % Growth | 2.8% | -11.6% | 27.4% | – |
| Gross Profit | $15,604 | -$59,640 | $90,151 | $107,001 |
| % Margin | 2% | -7.8% | 10.4% | 15.7% |
| EBITDA | -$435,456 | -$219,644 | -$9,418 | -$826 |
| % Margin | -55.3% | -28.6% | -1.1% | -0.1% |
| Net Income | -$260,487 | -$140,753 | -$28,150 | -$301,725 |
| % Margin | -33.1% | -18.4% | -3.2% | -44.3% |
| EPS Diluted | -49.35 | -26.67 | -5.59 | -61.7 |
| % Growth | -85% | -377.1% | 90.9% | – |
| Operating Cash Flow | -$39,711 | -$15,485 | -$29,470 | -$62,179 |
| Capital Expenditures | -$6,869 | -$6,190 | -$5,080 | -$10,468 |
| Free Cash Flow | -$46,580 | -$21,675 | -$34,550 | -$72,647 |